Yıl: 2023 Cilt: 31 Sayı: 1 Sayfa Aralığı: 69 - 77 Metin Dili: İngilizce DOI: 10.5606/tgkdc.dergisi.2023.23081 İndeks Tarihi: 30-05-2023

COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors

Öz:
Background: In this study, we aimed to analyze the risk factors of barotrauma in patients who were followed in the intensive care unit due to novel coronavirus disease 2019 (COVID-19) pneumonia. Methods: Between March 2020 and January 2021, a total of 261 patients (155 males, 106 females; mean age: 63.3±15.3 years; range, 11 to 91 years) who were followed in the intensive care unit due to COVID-19 pneumonia and were diagnosed with pneumothorax, pneumomediastinum, and subcutaneous emphysema were retrospectively analyzed. Demographics data of the patients, past and current medical history, clinical management, patient progress, and survival data were obtained from medical records of our hospital. Results: Twenty-seven of the patients were diagnosed with barotrauma. A total of 88.8% of the patients were followed with intubation. The development of pneumothorax, pneumomediastinum, and subcutaneous emphysema due to barotrauma was not dependent on sex, smoking/non-smoking status, using/not using corticosteroids, or comorbid diseases. There was a significant correlation between pneumothorax, pneumomediastinum, and subcutaneous emphysema development in intubated patients with different ventilator modes. Changing the ventilator mode from synchronized intermittent mandatory ventilation to airway pressure release ventilation increased the possibility of barotrauma by 15 times. Conclusion: Despite all lung-protective applications, barotrauma is a common complication, particularly in mechanically ventilated patients who have COVID-19 pneumonia with severe acute respiratory distress syndrome. Mechanical ventilator pressure modes should be patient- specific and followed carefully and frequently for the risk of barotrauma.
Anahtar Kelime:

COVID-19 ve pnömotoraks, pnömomediastinum, subkütanöz amfizem: Risk faktörlerinin analizi

Öz:
Amaç: Bu çalışmada yeni koronavirüs hastalığı 2019 (COVID-19) pnömonisine bağlı yoğun bakım ünitesinde takip edilen hastalarda barotravmanın risk faktörleri incelendi. Ça lışma planı:Mart 2020 - Ocak 2021 tarihleri arasında COVID-19 pnömonisi nedeniyle yoğun bakım ünitesinde takip edilen ve pnömotoraks, pnömomediastinum ve subkutan amfizem tanısı konan toplam 261 hasta (155 erkek, 106 kadın; ort. yaş: 63.3±15.3 yıl; dağılım, 11-91 yıl) retrospektif olarak incelendi. Hastaların demografik verileri, geçmiş ve şimdiki tıbbi öyküleri, klinik tedavileri, hasta durumları ve sağkalım verileri hastanemizin tıbbi kayıtlarından elde edildi. Bulgular: Hastaların 27’sine barotravma tanısı kondu. Hastaların toplam %88.8’i entübe olarak takip edildi. Barotravmaya bağlı pnömotoraks, pnömomediastinum ve subkutan amfizem cinsiyet, sigara kullanma/kullanmama durumu, kortikosteroid kullanma/kullanmama durumu ve eşlik eden hastalıklardan bağımsız idi. Farklı ventilatör modlarının kullanıldığı entübe hastalarda pnömotoraks, pnömomediastinum ve subkutan amfizem gelişimi arasında anlamlı bir ilişki izlendi. Ventilatör modunun senkronize aralıklı zorunlu ventilasyondan hava yolu basıncı serbestleştirme ventilasyona geçirilmesi, barotravma olasılığını 15 kat artırdı. So nuç: Akciğeri koruyan tüm uygulamalara rağmen, barotravma özellikle mekanik ventilasyonlu şiddetli akut solunum sıkıntısı sendromlu COVID-19 pnömoni hastalarında sık görülen bir komplikasyondur. Mekanik ventilatör basınç modları hastaya göre olmalıdır ve barotravma riski nedeniyle hastalar dikkatli ve sıklıkla takip edilmelidir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. COVID-19. Map-Johns Hopkins Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu [Accessed: October 01, 2021]
  • 2. Shan S, Guangming L, Wei L, Xuedong Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19: Case report and literature review. Rev Inst Med Trop Sao Paulo 2020;62:e76. doi: 10.1590/ s1678-9946202062076
  • 3. Zhou C, Gao C, Xie Y, Xu M. COVID-19 with spontaneous pneumomediastinum. Lancet Infect Dis 2020;20:510. doi: 10.1016/S1473-3099(20)30156-0
  • 4. Wali A, Rizzo V, Bille A, Routledge T, Chambers AJ. Pneumomediastinum following intubation in COVID-19 patients: A case series. Anaesthesia 2020;75:1076-81. doi: 10.1111/anae.15113
  • 5. Ezeagu R, Olanipekun T, Santoshi R, Seneviratne C, Kupfer Y. Pulmonary barotrauma resulting from mechanical ventilation in 2 patients with a diagnosis of COVID-19 pneumonia. Am J Case Rep 2021;22:e927954. doi: 10.12659/ AJCR.927954
  • 6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13. doi: 10.1016/ S0140-6736(20)30211-7
  • 7. Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Analysis of 92 deceased patients with COVID-19. J Med Virol 2020;92:2511-5. doi: 10.1002/jmv.25891
  • 8. Lemmers DHL, Abu Hilal M, Bnà C, Prezioso C, Cavallo E, Nencini N, et al. Pneumomediastinum and subcutaneous emphysema in COVID-19: Barotrauma or lung frailty? ERJ Open Res 2020;6:00385-2020. doi: 10.1183/23120541.00385-2020
  • 9. Wong K, Kim DH, Iakovou A, Khanijo S, Tsegaye A, Hahn S, et al. Pneumothorax in COVID-19 acute respiratory distress syndrome: Case series. Cureus 2020;12:e11749. doi: 10.7759/cureus.11749
  • 10. Kukuruza K, Aboeed A. Subcutaneous Emphysema. 2022 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
  • 11. Housman B, Jacobi A, Carollo A, Nobel T, Eber C, Acquah S, et al. COVID-19 ventilator barotrauma management: Less is more. Ann Transl Med 2020;8:1575. doi: 10.21037/ atm-20-3907
  • 12. McGuinness G, Zhan C, Rosenberg N, Azour L, Wickstrom M, Mason DM, et al. Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology 2020;297:E252-E262. doi: 10.1148/ radiol.2020202352
  • 13. Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis 2020;95:304-7. doi: 10.1016/j.ijid.2020.04.061
  • 14. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846-8. doi: 10.1007/s00134-020-05991-x
  • 15. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-4. doi: 10.1016/ S0140-6736(20)30628-0
  • 16. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID- 19 in Wuhan, China: A retrospective cohort study. Lancet 2020;395:1054-62. doi: 10.1016/S0140-6736(20)30566-3
  • 17. Niehaus M, Rusgo A, Roth K, Jacoby JL. Retropharyngeal air and pneumomediastinum: A rare complication of influenza A and asthma in an adult. Am J Emerg Med 2016;34:338.e1-2. doi: 10.1016/j.ajem.2015.06.020
APA bilgin buyukkarabacak y, PIRZIRENLI G, Gurz S, ABACI S, Taslak Sengul A, Celik B, basoglu a (2023). COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. , 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
Chicago bilgin buyukkarabacak yasemin,PIRZIRENLI GOKHAN,Gurz Selcuk,ABACI SAMET HASAN,Taslak Sengul Aysen,Celik Burcin,basoglu ahmet COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. (2023): 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
MLA bilgin buyukkarabacak yasemin,PIRZIRENLI GOKHAN,Gurz Selcuk,ABACI SAMET HASAN,Taslak Sengul Aysen,Celik Burcin,basoglu ahmet COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. , 2023, ss.69 - 77. 10.5606/tgkdc.dergisi.2023.23081
AMA bilgin buyukkarabacak y,PIRZIRENLI G,Gurz S,ABACI S,Taslak Sengul A,Celik B,basoglu a COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. . 2023; 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
Vancouver bilgin buyukkarabacak y,PIRZIRENLI G,Gurz S,ABACI S,Taslak Sengul A,Celik B,basoglu a COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. . 2023; 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
IEEE bilgin buyukkarabacak y,PIRZIRENLI G,Gurz S,ABACI S,Taslak Sengul A,Celik B,basoglu a "COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors." , ss.69 - 77, 2023. 10.5606/tgkdc.dergisi.2023.23081
ISNAD bilgin buyukkarabacak, yasemin vd. "COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors". (2023), 69-77. https://doi.org/10.5606/tgkdc.dergisi.2023.23081
APA bilgin buyukkarabacak y, PIRZIRENLI G, Gurz S, ABACI S, Taslak Sengul A, Celik B, basoglu a (2023). COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. Türk Göğüs Kalp Damar Cerrahisi Dergisi, 31(1), 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
Chicago bilgin buyukkarabacak yasemin,PIRZIRENLI GOKHAN,Gurz Selcuk,ABACI SAMET HASAN,Taslak Sengul Aysen,Celik Burcin,basoglu ahmet COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. Türk Göğüs Kalp Damar Cerrahisi Dergisi 31, no.1 (2023): 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
MLA bilgin buyukkarabacak yasemin,PIRZIRENLI GOKHAN,Gurz Selcuk,ABACI SAMET HASAN,Taslak Sengul Aysen,Celik Burcin,basoglu ahmet COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. Türk Göğüs Kalp Damar Cerrahisi Dergisi, vol.31, no.1, 2023, ss.69 - 77. 10.5606/tgkdc.dergisi.2023.23081
AMA bilgin buyukkarabacak y,PIRZIRENLI G,Gurz S,ABACI S,Taslak Sengul A,Celik B,basoglu a COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. Türk Göğüs Kalp Damar Cerrahisi Dergisi. 2023; 31(1): 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
Vancouver bilgin buyukkarabacak y,PIRZIRENLI G,Gurz S,ABACI S,Taslak Sengul A,Celik B,basoglu a COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors. Türk Göğüs Kalp Damar Cerrahisi Dergisi. 2023; 31(1): 69 - 77. 10.5606/tgkdc.dergisi.2023.23081
IEEE bilgin buyukkarabacak y,PIRZIRENLI G,Gurz S,ABACI S,Taslak Sengul A,Celik B,basoglu a "COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors." Türk Göğüs Kalp Damar Cerrahisi Dergisi, 31, ss.69 - 77, 2023. 10.5606/tgkdc.dergisi.2023.23081
ISNAD bilgin buyukkarabacak, yasemin vd. "COVID-19 and pneumothorax, pneumomediastinum, subcutaneous emphysema: Analysis of risk factors". Türk Göğüs Kalp Damar Cerrahisi Dergisi 31/1 (2023), 69-77. https://doi.org/10.5606/tgkdc.dergisi.2023.23081